CoChat

The effect of myo‐inositol/di‐chiro‐inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta‐analysis

Bhide, Priya, Pundir, Jyotsna, Gudi, Anil, Shah, Amit, Homburg, Roy, Acharya, Ganesh · 2019 · Acta Obstetricia et Gynecologica Scandinavica
Cited by 22

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Introduction: High levels of anti‐Mullerian hormone and a high antral follicle count in women with polycystic ovary syndrome, reflecting increased ovarian antral follicles, predisposes them to have a high number of retrieved oocytes with in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) and an increased risk of ovarian hyperstimulation syndrome. Inositols, which act as insulin sensitizers, have the potential to alter folliculogenesis and the functional ovarian reserve, with subsequent benefits to reproductive outcomes following IVF/ICSI treatment. Published literature is, however, unable to provide definitive evidence of its efficacy. The objective of our review was to evaluate the effect of inositols on anti‐Mullerian hormone, antral follicle count and reproductive outcomes in women with polycystic ovary syndrome undergoing IVF/ICSI. Material and methods: We performed a literature search using standard methodology recommended by Cochrane. Randomized controlled trials and non‐randomized studies comparing inositols with no treatment, placebo or other treatment were included in the review. Using standard methodology recommended by Cochrane we pooled results using the random effects model; our findings were reported as relative risk or mean differences. PROSPERO registration: CRD42017082275. Results: We included 18 trials. The primary outcome was a change in anti‐Mullerian hormone and antral follicle count before and after treatment, for which data were unsuitable for meta‐analysis. A narrative review showed no consistent direction or size of effect. A meta‐analysis for the secondary outcomes showed no evidence of a significant difference between inositol and control groups for any outcome: number of oocytes (mean difference −0.39, 95% confidence interval [CI] −1.11 to 0.33), number of metaphase II oocytes (mean difference 0.29, 95% CI −0.83 to 1.40), number of top grade embryos (risk ratio [RR] 1.02, 95% CI 0.93‐1.12), clinical pregnancy rate (RR 1.16, 95% CI 0.87‐1.53), and risk of ovarian hyperstimulation syndrome (RR 0.73, 95% CI 0.39‐1.37). The quality of evidence was assessed as very low. Conclusions: There is insufficient evidence for an effect of inositols on ovarian reserve markers and to support their use as pretreatment before IVF/ICSI in women with polycystic ovary syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/aogs.13625

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 9 references

Cited by

See all 22

Metadata

Authors
Bhide, P., Pundir, J., Gudi, A., Shah, A., Homburg, R., & Acharya, G.
Venue
Acta Obstetricia et Gynecologica Scandinavica
Publisher
Wiley
Published
2019-05-20
Volume
98
Issue
10
Pages
1235-1244
ISSN
  • 0001-6349 (ISSN-L)
  • 1600-0412
OpenAlex
W2937821826
Cited by
22
References
9
FWCI
0.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of myo‐inositol/di‐chiro‐inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1111/aogs.13625
The paper
Bhide, P., Pundir, J., Gudi, A., Shah, A., Homburg, R., & Acharya, G. (2019). The effect of myo‐inositol/di‐chiro‐inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.13625

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.